{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:53:43Z","timestamp":1765886023752,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"University of California San Francisco, Global Health Group","award":["A115501"],"award-info":[{"award-number":["A115501"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12936-016-1410-7","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T09:26:53Z","timestamp":1469179613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5021-8345","authenticated-orcid":false,"given":"Eugenie","family":"Poirot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Soble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nyasatu","family":"Ntshalintshali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asen","family":"Mwandemele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nomcebo","family":"Mkhonta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calisile","family":"Malambe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibonakaliso","family":"Vilakati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Darteh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gugu","family":"Maphalala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joelle","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Stergachis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Vittinghoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Kunene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Gosling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,22]]},"reference":[{"key":"1410_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1473-3099(12)70198-6","volume":"13","author":"NJ White","year":"2013","unstructured":"White NJ. Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis. 2013;13:175\u201381.","journal-title":"Lancet Infect Dis"},{"key":"1410_CR2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1086\/503051","volume":"193","author":"JT Bousema","year":"2006","unstructured":"Bousema JT, Schneider P, Gouagna LC, Drakeley CJ, Tostmann A, Houben R, et al. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J Infect Dis. 2006;193:1151\u20139.","journal-title":"J Infect Dis"},{"key":"1410_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-3156.2003.01169.x","volume":"9","author":"CJ Drakeley","year":"2004","unstructured":"Drakeley CJ, Jawara M, Targett GA, Walraven G, Obisike U, Coleman R, et al. Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Trop Med Int Health. 2004;9:53\u201361.","journal-title":"Trop Med Int Health"},{"key":"1410_CR4","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/319689","volume":"183","author":"G Targett","year":"2001","unstructured":"Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, Deen J, et al. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis. 2001;183:1254\u20139.","journal-title":"J Infect Dis"},{"key":"1410_CR5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11908-007-0021-4","volume":"9","author":"JK Baird","year":"2007","unstructured":"Baird JK, Schwartz E, Hoffman SL. Prevention and treatment of vivax malaria. Curr Infect Dis Rep. 2007;9:39\u201346.","journal-title":"Curr Infect Dis Rep"},{"key":"1410_CR6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4269\/ajtmh.2006.75.402","volume":"75","author":"DR Hill","year":"2006","unstructured":"Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg. 2006;75:402\u201315.","journal-title":"Am J Trop Med Hyg"},{"key":"1410_CR7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/CMR.00051-10","volume":"24","author":"T Bousema","year":"2011","unstructured":"Bousema T, Drakeley C. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev. 2011;24:377\u2013410.","journal-title":"Clin Microbiol Rev"},{"key":"1410_CR8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","volume":"371","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64\u201374.","journal-title":"Lancet"},{"key":"1410_CR9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1475-2875-13-418","volume":"13","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014;13:418.","journal-title":"Malar J"},{"key":"1410_CR10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.1962.03050180034008a","volume":"180","author":"RW Kellermeyer","year":"1962","unstructured":"Kellermeyer RW, Tarlov AR, Brewer GJ, Carson PE, Alving AS. Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis. JAMA. 1962;180:388\u201394.","journal-title":"JAMA"},{"key":"1410_CR11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjh.12665","volume":"164","author":"L Luzzatto","year":"2014","unstructured":"Luzzatto L, Seneca E. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol. 2014;164:469\u201380.","journal-title":"Br J Haematol"},{"key":"1410_CR12","unstructured":"Updated WHO policy recommendation: single dose Primaquine as a gametocytocide in Plasmodium falciparum malaria. Geneva: World Health Organization; 2012. (Press release)."},{"key":"1410_CR13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1475-2875-11-418","volume":"11","author":"NJ White","year":"2012","unstructured":"White NJ, Qiao LG, Qi G, Luzzatto L. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. Malar J. 2012;11:418.","journal-title":"Malar J"},{"key":"1410_CR14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2875-5-50","volume":"5","author":"AO Talisuna","year":"2006","unstructured":"Talisuna AO, Staedke SG, D\u2019Alessandro U. Pharmacovigilance of antimalarial treatment in Africa: is it possible? Malar J. 2006;5:50.","journal-title":"Malar J"},{"key":"1410_CR15","volume-title":"Safety of 8-aminoquinoline antimalarial medicines","author":"J Recht","year":"2014","unstructured":"Recht J, Ashley E, White N. Safety of 8-aminoquinoline antimalarial medicines. Geneva: World Health Organization; 2014."},{"key":"1410_CR16","unstructured":"Agency EM. ICH Topic E 2 A: clinical safety data management: definitions and standards for expedited reporting. 1995."},{"key":"1410_CR17","volume-title":"Toxicity grading scale for determining the severity of adverse events","author":"WHO","year":"2003","unstructured":"WHO. Toxicity grading scale for determining the severity of adverse events. Geneva: World Health Organization; 2003."},{"key":"1410_CR18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa031688","volume":"350","author":"P Hillmen","year":"2004","unstructured":"Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2004;350:552\u20139.","journal-title":"N Engl J Med"},{"key":"1410_CR19","unstructured":"Malaria Surveillance Database System (Internet)."},{"key":"1410_CR20","unstructured":"WHO. Management of severe malaria: a practical handbook. 3rd ed. Geneva: World Health Organization; 2012."},{"key":"1410_CR21","unstructured":"WHO. Haemoglobin concentrations for the diagnosis of anemia and assessment of severity. Geneva: World Health Organization; 2011."},{"key":"1410_CR22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-3156.2008.02119.x","volume":"13","author":"H Bukirwa","year":"2008","unstructured":"Bukirwa H, Nayiga S, Lubanga R, Mwebaza N, Chandler C, Hopkins H, et al. Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events. Trop Med Int Health. 2008;13:1143\u201352.","journal-title":"Trop Med Int Health"},{"key":"1410_CR23","doi-asserted-by":"crossref","first-page":"25606","DOI":"10.3402\/gha.v7.25606","volume":"7","author":"CS Hall","year":"2014","unstructured":"Hall CS, Fottrell E, Wilkinson S, Byass P. Assessing the impact of mHealth interventions in low- and middle-income countries\u2014what has been shown to work? Glob Health Action. 2014;7:25606.","journal-title":"Glob Health Action"},{"key":"1410_CR24","doi-asserted-by":"crossref","first-page":"e1001176","DOI":"10.1371\/journal.pmed.1001176","volume":"9","author":"D Zurovac","year":"2012","unstructured":"Zurovac D, Talisuna AO, Snow RW. Mobile phone text messaging: tool for malaria control in Africa. PLoS Med. 2012;9:e1001176.","journal-title":"PLoS Med"},{"key":"1410_CR25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jdeveco.2011.07.001","volume":"98","author":"J Das","year":"2012","unstructured":"Das J, Hammer J, Sanchez-Paramo C. The impact of recall periods on reported morbidity and health seeking behavior. J Dev Econ. 2012;98:76\u201388.","journal-title":"J Dev Econ"},{"key":"1410_CR26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1475-2875-12-391","volume":"12","author":"GJ Domingo","year":"2013","unstructured":"Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J. 2013;12:391.","journal-title":"Malar J"},{"key":"1410_CR27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12936-015-0714-3","volume":"14","author":"I Chen","year":"2015","unstructured":"Chen I, Poirot E, Newman M, Kandula D, Shah R, Hwang J, et al. An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa. Malar J. 2015;14:204.","journal-title":"Malar J"},{"key":"1410_CR28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1586\/17512433.2014.948421","volume":"7","author":"IT Chen","year":"2014","unstructured":"Chen IT, Gosling RD. Targeting Plasmodium falciparum transmission with primaquine: same efficacy, improved safety with a lower dose? Expert Rev Clin Pharmacol. 2014;7:681\u20136.","journal-title":"Expert Rev Clin Pharmacol"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1410-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T12:21:35Z","timestamp":1568204495000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-016-1410-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,22]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1410"],"URL":"https:\/\/doi.org\/10.1186\/s12936-016-1410-7","relation":{},"ISSN":["1475-2875"],"issn-type":[{"type":"electronic","value":"1475-2875"}],"subject":[],"published":{"date-parts":[[2016,7,22]]},"article-number":"384"}}